Baumer S.A. (BVMF:BALM3)

Market Cap	193.14M
Revenue (ttm)	218.37M
Net Income (ttm)	28.45M
Shares Out	n/a
EPS (ttm)	2.91
PE Ratio	6.79
Forward PE	n/a
Dividend	1.43 (6.50%)
Ex-Dividend Date	Oct 3, 2025

Volume	300
Average Volume	100
Open	20.90
Previous Close	22.00
Day's Range	20.90 - 20.90
52-Week Range	11.35 - 23.98
Beta	0.42
RSI	43.15
Earnings Date	Nov 11, 2025

About Baumer

Baumer S.A. engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. The company offers drugs for bone regeneration, including membrane and graft; and equipment for safe environment, disinfection, preparing and inspecting, water treatment, sterilization, transfer, storage, transport, surgical room, and cleaning. It also provides orthopedic devices, such as conventional prosthesi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1952
• Employees: 306
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BALM3

Financial Performance

In 2024, Baumer's revenue was 194.39 million, an increase of 14.38% compared to the previous year's 169.95 million. Earnings were 31.61 million, an increase of 243.92%.